$10.02
0.212.14%
At Close: -
$10.02
00.00%
After Hours: Jul 5, 4:00 PM EDT
15 minutes delayed
Amicus Therapeutics
FOLDNASDAQ
Amicus Therapeutics (NASDAQ:FOLD) Stock, Earnings Estimates, EPS, And Revenue
Amicus Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 9
EPS
$-0.020
Quarterly Revenue
$110.4M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$423.5M
Analyze the earnings history of Amicus Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FOLD | Amicus Therapeutics | -$0.15 | — | — | — | $94.50M | — | — | — | 08/06/2024 | Get Alert |
| FOLD | Amicus Therapeutics | -$0.06 | -$0.07 | -$0.02 | 71.43% | $86.27M | $111.19M | $110.40M | -0.71% | 05/09/2024 | Get Alert |
| FOLD | Amicus Therapeutics | -$0.19 | -$0.06 | $0.01 | 116.67% | $88.10M | $114.33M | $115.08M | 0.65% | 02/28/2024 | Get Alert |
| FOLD | Amicus Therapeutics | -$0.12 | -$0.08 | -$0.07 | 12.50% | $81.69M | $101.36M | $103.50M | 2.11% | 11/08/2023 | Get Alert |
| FOLD | Amicus Therapeutics | -$0.21 | -$0.12 | -$0.15 | -25.00% | $80.73M | $89.87M | $94.50M | 5.16% | 08/08/2023 | Get Alert |
| FOLD | Amicus Therapeutics | -$0.30 | -$0.15 | -$0.18 | -20.00% | $78.72M | $83.08M | $86.27M | 3.84% | 05/10/2023 | Get Alert |
| FOLD | Amicus Therapeutics | -$0.29 | -$0.13 | -$0.19 | -46.15% | $82.15M | $86.29M | $88.10M | 2.09% | 03/01/2023 | Get Alert |
| FOLD | Amicus Therapeutics | -$0.19 | -$0.19 | -$0.12 | 36.84% | $79.55M | $84.22M | $81.69M | -3.00% | 11/07/2022 | Get Alert |
| FOLD | Amicus Therapeutics | -$0.19 | -$0.22 | -$0.21 | 4.55% | $77.41M | $85.89M | $80.73M | -6.01% | 08/04/2022 | Get Alert |
| FOLD | Amicus Therapeutics | -$0.25 | -$0.25 | -$0.30 | -20.00% | $66.40M | $77.13M | $78.72M | 2.05% | 05/09/2022 | Get Alert |
| FOLD | Amicus Therapeutics | -$0.27 | -$0.16 | -$0.29 | -81.25% | $70.57M | $83.28M | $82.15M | -1.35% | 02/24/2022 | Get Alert |
| FOLD | Amicus Therapeutics | -$0.22 | -$0.18 | -$0.19 | -5.56% | $67.44M | $80.11M | $79.55M | -0.71% | 11/09/2021 | Get Alert |
| FOLD | Amicus Therapeutics | -$0.20 | -$0.22 | -$0.19 | 13.64% | $62.35M | $73.36M | $77.41M | 5.52% | 08/05/2021 | Get Alert |
| FOLD | Amicus Therapeutics | -$0.35 | -$0.24 | -$0.25 | -4.17% | $60.52M | $71.65M | $66.40M | -7.32% | 05/10/2021 | Get Alert |
| FOLD | Amicus Therapeutics | -$0.35 | -$0.23 | -$0.27 | -17.39% | $55.29M | $70.06M | $70.57M | 0.73% | 03/01/2021 | Get Alert |
| FOLD | Amicus Therapeutics | -$0.24 | -$0.22 | -$0.22 | 0.00% | $48.77M | $65.10M | $67.44M | 3.59% | 11/05/2020 | Get Alert |
| FOLD | Amicus Therapeutics | -$0.36 | -$0.26 | -$0.20 | 23.08% | $44.13M | $62.38M | $62.35M | -0.04% | 08/10/2020 | Get Alert |
| FOLD | Amicus Therapeutics | -$0.39 | -$0.28 | -$0.35 | -25.00% | $34.05M | $57.49M | $60.52M | 5.28% | 05/07/2020 | Get Alert |
| FOLD | Amicus Therapeutics | -$0.41 | -$0.27 | -$0.35 | -29.63% | $32.64M | $52.33M | $55.29M | 5.66% | 03/02/2020 | Get Alert |
| FOLD | Amicus Therapeutics | -$0.31 | -$0.32 | -$0.24 | 25.00% | $20.60M | $47.66M | $48.77M | 2.32% | 11/11/2019 | Get Alert |
| FOLD | Amicus Therapeutics | -$0.33 | -$0.33 | -$0.36 | -9.09% | $21.31M | $41.13M | $44.13M | 7.29% | 08/08/2019 | Get Alert |
Amicus Therapeutics (FOLD) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-09 | $-0.02 | $-0.07 | 71.4 % |
| Dec 2023 | 2024-02-28 | $0.01 | $-0.06 | 116.7 % |
| Sep 2023 | 2023-11-08 | $-0.07 | $-0.08 | 12.5 % |
| Jun 2023 | 2023-08-08 | $-0.15 | $-0.12 | -25.0 % |
Amicus Therapeutics (FOLD) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-09 | $110.40M | $111.19M | -0.71 % |
| Dec 2023 | 2024-02-28 | $115.08M | $114.34M | 0.65 % |
| Sep 2023 | 2023-11-08 | $103.50M | $101.36M | 2.11 % |
| Jun 2023 | 2023-08-08 | $94.50M | $89.87M | 5.16 % |
FAQ
When is Amicus Therapeutics (NASDAQ:FOLD) reporting earnings?
Amicus Therapeutics (FOLD) is scheduled to report earnings on August 6, 2024. The last reported earnings were for reported on May 9, 2024 for Q1.
What were the latest earnings per share (EPS) for Amicus Therapeutics (NASDAQ:FOLD)?
The Actual EPS was $-0.02, which beat the estimate of $-0.07.
What were Amicus Therapeutics’s (NASDAQ:FOLD) revenues?
The Actual Revenue was $110.4M, which missed the estimate of $111.2M.
Browse earnings estimates, EPS, and revenue on all stocks.